Veterinary Robotic Surgery Enablers Market Report 2026

The veterinary robotic surgery enablers market size has grown rapidly in recent years. It will grow from $1.09 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to increasing demand for minimally invasive veterinary surgeries, rising adoption of advanced diagnostic imaging systems, growth in companion animal surgical procedures, limited availability of skilled veterinary surgeons, early adoption of robotic-assisted human surgical technologies influencing veterinary use.

The veterinary robotic surgery enablers market size is expected to see rapid growth in the next few years. It will grow to $2.09 billion by 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to expansion of ai-driven surgical robotics platforms, increasing investment in veterinary automation infrastructure, rising demand for precision and error-free surgical outcomes, integration of real-time imaging and navigation systems, growth in tele-operated and remote robotic surgery capabilities. Major trends in the forecast period include rising adoption of ai-assisted robotic surgical decision support systems in veterinary procedures, increasing integration of precision imaging-guided robotic navigation for minimally invasive animal surgeries, expansion of automated robotic instrument calibration and control systems in veterinary operating rooms, growing deployment of cloud-connected robotic surgery platforms for remote monitoring and analytics, increasing use of high-precision multi-articulating robotic instruments for complex veterinary surgical procedures.

The rising pet ownership is expected to propel the growth of the veterinary robotic surgery enablers market going forward. A pet is an animal kept by humans primarily for companionship, emotional connection, or personal enjoyment rather than for economic or utilitarian purposes. Pet ownership is increasing due to growing social isolation and stress in modern lifestyles, encouraging more individuals to adopt animals as companions to enhance emotional well-being and alleviate loneliness. Rising pet ownership is boosting the demand for veterinary robotic surgery enablers, as an increasing number of pet owners seek advanced, minimally invasive procedures that provide greater precision and faster recovery for their animals. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit trade association, pet ownership has rebounded, with 94 million U. S. households owning at least one pet, up from 82 million in 2023, and overall ownership has increased for both dogs and cats, with dogs present in 51% of households (68 million) and cats in 37% (49 million). Therefore, the rising pet ownership is driving the growth of the veterinary robotic surgery enablers market.

Leading companies operating in the veterinary robotic surgery enablers market are focusing on advancing robotic-assisted surgical solutions, such as minimally invasive robotic gastropexy, to improve surgical precision, enhance clinical outcomes, and expand the adoption of robotics in veterinary care. Robotic gastropexy refers to a minimally invasive surgical procedure performed with robotic assistance to prevent gastric dilatation-volvulus (GDV) by attaching the stomach to the abdominal wall, enabling greater precision and shorter recovery time compared to conventional methods. For instance, in January 2024, R2 Surgical, a US-based medical technology company, partnered with Cornell University College of Veterinary Medicine to conduct the first live animal robotic-assisted gastropexy using its Dexter robotic system. This milestone procedure demonstrated the system’s capability to support minimally invasive veterinary surgeries with enhanced dexterity, improved visualization, and greater surgeon control, representing a significant advancement in the integration of robotic technologies into veterinary surgical practice.

In February 2025, Anicom Group, a Japan-based pet insurance and animal healthcare services company, partnered with Riverfield Inc., to jointly develop surgical assist robots and robotic surgery enabling technologies for veterinary applications. Through this partnership, Anicom Group and Riverfield Inc. aim to speed up the development and rollout of veterinary robotic surgery platforms, improve surgical accuracy, enhance clinical outcomes for animals, and broaden access to advanced robotic-assisted veterinary care. Riverfield Inc. is a Japan-based medical robotics company focused on surgical assist systems and robotic platforms.

Major companies operating in the veterinary robotic surgery enablers market are Johnson & Johnson, Medtronic plc, Karl Storz SE & Co. KG, Stäubli International AG, Renishaw plc, Accuray Incorporated, Meere Company Inc., Kinova Inc., CMR Surgical Ltd., Mecademic Inc., Vicarious Surgical Inc., Shanghai MicroPort MedBot Co. Ltd., Mindray Medical International Limited, Robocath Inc., R2 Surgical Inc., Panda Surgical Inc., VetOvation Inc., Avante Health Solutions, Apixia Inc., Harbin Sagebot Intelligent Medical Equipment Co. Ltd.

North America was the largest region in the veterinary robotic surgery enablers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary robotic surgery enablers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary robotic surgery enablers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary robotic surgery enablers market consists of revenues earned by entities by providing services such as consulting and workflow optimization services, data management and analytics services, and cybersecurity and data protection services. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary robotic surgery enablers market also includes sales of precision surgical sensors, end-effector devices, and camera control units. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.